CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishSerum doxofylline concentrations were evaluated after solid-phase extraction byhigh-performance liquid chromatography following administration of 100 mg doxofylline given as a single intravenous dose over 10 min or 400 mg doxofylline given orally twice daily for 5 days in six and eight non-smoking, fasting, chronic bronchitic patients, respectively. Doxofylline possessed a very short distribution phase following intravenous administration, with a sustained elimination phase (half-life 1.83 ± 0.37 h). After oral administration, the peak serum doxofylline concentration was 15.21 ± 1.73 μg/ml and the mean elimination half-life was 7.01 ± 0.80 h; there was a large inter-subject variability. No side-effects were experienced by the patients during the study.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
| Titolo: | Oral and intravenous pharmacokinetic profiles of doxofylline in patients with chronic bronchitis |
| Autori: | |
| Data di pubblicazione: | 1990 |
| Rivista: | |
| Citazione: | Oral and intravenous pharmacokinetic profiles of doxofylline in patients with chronic bronchitis / E., Bologna; Lagana', Aldo; D., Terracino; P., Bolignari; P., Biffignandi. - In: JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. - ISSN 0300-0605. - STAMPA. - 18:4(1990), pp. 282-288. |
| Handle: | http://hdl.handle.net/11573/431873 |
| Appartiene alla tipologia: | 01a Articolo in rivista |
File allegati a questo prodotto
Copyright © 2020